GO
Loading...

Bristol-Isis Drug Deal

Wednesday, 9 May 2007 | 11:17 AM ET

Bristol-Myers Squibb strikes a $200 million deal with Isis Pharmaceuticals to further develop a new cholesterol drug, and Stanley Crooke, Isis Pharmaceuticals chairman & CEO, discusses the partnership with Mike Huckman, CNBC's pharmaceuticals reporter